Thiadiazole or oxadiazole analogs of fenamic acids containing su

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514364, 548143, 548144, 548136, 548138, C07D271113, C07D285125, A61K 3141

Patent

active

052121895

ABSTRACT:
The present invention is a novel compound which is a thiadiazole or oxadiazole analog of a fenamic acid having a substituted hydroxamate side chain and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use thereof. The invention compounds are now found to have activity as inhibitors of one or both of cyclooxygenase and 5-lipoxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever, and the like. Thus, the present invention is also a pharmaceutical composition or method of use thereof.

REFERENCES:
patent: 3413313 (1968-11-01), Scherrer
patent: 4092430 (1978-05-01), Sallmann et al.
patent: 4981865 (1991-01-01), Belliotti
patent: 5017604 (1991-05-01), Beliotti et al.
Derwent Abstract 87-130305/19 for NL 8602-610-A & DE 3636413.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiadiazole or oxadiazole analogs of fenamic acids containing su does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiadiazole or oxadiazole analogs of fenamic acids containing su, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiadiazole or oxadiazole analogs of fenamic acids containing su will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-804717

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.